TrialJournal of neuro-oncology2019

Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma.

Andrew B Lassman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.